Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study

por Humbert, Marc, Taillé, Camille, Mala, Laurence, Le Gros, Vincent, Just, Jocelyne, Molimard, Mathieu
Publicado 2018

Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study

por Just, Jocelyne, Thonnelier, Celine, Bourgoin-Heck, Melisande, Mala, Laurence, Molimard, Mathieu, Humbert, Marc
Publicado 2021

Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL

por Menzella, Francesco, Just, Jocelyne, Sauerbeck, Inessa Schwab, Mailaender, Claudia, Saccheri, Fabiana, Thonnelier, Celine, Jaumont, Xavier, Mala, Laurence
Publicado 2023